Correlation Between Cue Biopharma and Landos Biopharma
Can any of the company-specific risk be diversified away by investing in both Cue Biopharma and Landos Biopharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cue Biopharma and Landos Biopharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cue Biopharma and Landos Biopharma, you can compare the effects of market volatilities on Cue Biopharma and Landos Biopharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cue Biopharma with a short position of Landos Biopharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cue Biopharma and Landos Biopharma.
Diversification Opportunities for Cue Biopharma and Landos Biopharma
-0.17 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cue and Landos is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding Cue Biopharma and Landos Biopharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Landos Biopharma and Cue Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cue Biopharma are associated (or correlated) with Landos Biopharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Landos Biopharma has no effect on the direction of Cue Biopharma i.e., Cue Biopharma and Landos Biopharma go up and down completely randomly.
Pair Corralation between Cue Biopharma and Landos Biopharma
If you would invest 139.00 in Cue Biopharma on November 4, 2024 and sell it today you would earn a total of 6.00 from holding Cue Biopharma or generate 4.32% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Cue Biopharma vs. Landos Biopharma
Performance |
| Timeline |
| Cue Biopharma |
| Landos Biopharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Cue Biopharma and Landos Biopharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cue Biopharma and Landos Biopharma
The main advantage of trading using opposite Cue Biopharma and Landos Biopharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cue Biopharma position performs unexpectedly, Landos Biopharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Landos Biopharma will offset losses from the drop in Landos Biopharma's long position.| Cue Biopharma vs. Coya Therapeutics, Common | Cue Biopharma vs. Lantern Pharma | Cue Biopharma vs. Fennec Pharmaceuticals | Cue Biopharma vs. Anixa Biosciences |
| Landos Biopharma vs. Apollomics Class A | Landos Biopharma vs. Cardio Diagnostics Holdings | Landos Biopharma vs. Transcode Therapeutics | Landos Biopharma vs. Xenetic Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.
Other Complementary Tools
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |